Titan International, Inc.
NYSE:TWIAgricultural - Machinery
+$0.24 today
- Market cap
- $283.62M
- Beta
- 1.47
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$1.36
Volume 0.77M
Average 0.93M
TWI Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Titan International, Inc.NYSE: TWI
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity falls 7.0% from a year ago
Total equity stood at $501.55M at the end of Q1 FY2026, down 7.0% from a year earlier and down 3.8% from the prior quarter. Over 3 fiscal years it compounded at +10.8% a year.
Context
- Total equity amounted to 29.2% of total assets at the end of Q1 FY2026, down 2.1 pp from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -7.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 521.62M USD
- Year-over-year change
- +5.7%
- 4-year CAGR
- +23.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 521.62M | +5.7% |
| FY2024 | 2024-12-31 | 493.66M | +5.6% |
| FY2023 | 2023-12-31 | 467.42M | +22.0% |
| FY2022 | 2022-12-31 | 383.14M | +68.7% |
| FY2021 | 2021-12-31 | 227.17M | — |
Total Equity vs competitors
How TWI compares with its peers on the latest reported figures
- TWI's Mar 2026 total equity of $501.55M is the 8th highest of the 11 companies compared; the peer median is $663.39M.
- Its year-over-year change of -7.0% is the 9th highest of 11, against a peer median of +4.1%.
- Total equity amounts to 29.2% of total assets for TWI, versus a peer median of 51.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.45B | +64.2% | +20.2% | 30.3% | |
| Mar 2026 | $843.19M | +2.0% | +2.5% | 59.4% | |
| Mar 2026 | $722.4M | +30.7% | +5.9% | 95.2% | |
| Mar 2026 | $685.9M | +5.3% | +8.9% | 37.2% | |
| Mar 2026 | $672M | -14.2% | -16.9% | 43.2% | |
| Mar 2026 | $654.79M | +2.6% | +7.8% | 82.9% | |
| Mar 2026 | $529.1M | +3.0% | -14.8% | 17.9% | |
| Mar 2026 | $501.55M | -7.0% | +10.8% | 29.2% | |
| Mar 2026 | $494.99M | +24.1% | -3.3% | 64.8% | |
| Mar 2026 | $407.6M | -8.1% | +2.3% | 40.1% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | $285.73M | +30.0% | +0.6% | 87.2% |
| Peer median (excluding TWI) | $663.39M | +4.1% | +2.4% | 51.3% | |
Competitors are the stored peer set for TWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 98.11M | 159.58M | 220.25M | 195.97M | 202.88M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 279.65M | 305.94M | 234.4M | 221.8M | 249.92M |
| Inventory | 392.62M | 397.22M | 365.16M | 437.19M | 470.55M |
| Other Current Assets | 25.59M | 23.84M | 8.24M | 32.03M | 37.45M |
| Total Current Assets | 813.3M | 909.63M | 876.78M | 912.04M | 985.97M |
| Property, Plant & Equipment (Net) | 322.05M | 305.54M | 333.65M | 538.25M | 568.14M |
| Goodwill | 0 | 0 | 0 | 29.56M | 29.56M |
| Intangible Assets | 8.2M | 7.08M | 7.27M | 15.44M | 22.24M |
| Long-term Investments | 6.52M | 6.95M | 7.13M | 7.92M | 15.33M |
| Tax Assets | 16.83M | 38.74M | 38.03M | 41.73M | 10.72M |
| Other Non-current Assets | 15.77M | 16.7M | 26.39M | 40.02M | 40.71M |
| Total Non-current Assets | 369.38M | 375M | 412.46M | 672.92M | 686.69M |
| Total Assets | 1.18B | 1.28B | 1.29B | 1.58B | 1.67B |
| Account Payables | 278.1M | 263.38M | 201.2M | 219.59M | 251.72M |
| Short-term Debt | 32.5M | 30.86M | 16.91M | 12.48M | 21.19M |
| Tax Payables | 9.27M | 18.55M | 13.76M | 12.14M | 0 |
| Deferred Revenue | 13.69M | 18.17M | 20M | 18.68M | 13.43M |
| Other Current Liabilities | 91.84M | 85.17M | 91.36M | 86.61M | 85.78M |
| Total Current Liabilities | 450.81M | 446.16M | 372.38M | 387.36M | 428.24M |
| Long-term Debt | 452.45M | 414.76M | 409.18M | 552.97M | 564.72M |
| Deferred Tax Liabilities | 3.98M | 3.43M | 2.23M | 6.42M | 6.14M |
| Deferred Revenue (Non-current) | 9.02M | 11.8M | 12.38M | 11.3M | 12.09M |
| Other Non-current Liabilities | 27.9M | 22.94M | 19.51M | 27.24M | 28.81M |
| Total Non-current Liabilities | 504.7M | 455.33M | 449.46M | 703.94M | 722.8M |
| Total Liabilities | 955.51M | 901.49M | 821.83M | 1.09B | 1.15B |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (85.44M) | 90.86M | 169.62M | 164.06M | 100.57M |
| Accumulated OCI | (246.48M) | (251.76M) | (219.04M) | (285.88M) | (209.03M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | (2.13M) | 1.9M | 355K | (2.42M) | 7.24M |
| Total Equity | 227.17M | 383.14M | 467.42M | 493.66M | 521.62M |
| Total Debt | 502.48M | 451.88M | 437.27M | 683.46M | 710.79M |
| Net Debt | 404.38M | 292.3M | 217.01M | 487.49M | 507.91M |
Titan International, Inc.
NYSE:TWI
Intrinsic Alpha fair value
Locked
Current Price
$4.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.